SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 79.10 |
Enterprise Value ($M) | -26.38 |
Book Value ($M) | 211.53 |
Book Value / Share | 2.57 |
Price / Book | 0.37 |
NCAV ($M) | 171.88 |
NCAV / Share | 2.09 |
Price / NCAV | 0.46 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.51 |
Return on Assets (ROA) | -0.57 |
Return on Equity (ROE) | -0.69 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 10.64 |
Current Ratio | 10.64 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 206.32 |
Assets | 245.96 |
Liabilities | 34.43 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Rtw Investments, Lp | 0.00 | -100.00 | |
13G/A | Tang Capital Management Llc | 9.97 | ||
13G/A | Commodore Capital Lp | 0.00 | -100.00 | |
13G/A | Ra Capital Management, L.p. | 9.99 | 7.95 | |
13G/A | Cowen Financial Products LLC | 0.00 | -100.00 | |
13G/A | Millennium Management Llc | 2.40 | -50.36 | |
13G/A | Morgan Stanley | 1.40 | -60.08 | |
13D/A | Orbimed Advisors Llc | 11.90 | 0.00 | |
13G/A | Tang Capital Partners Lp | 7.80 | 159.74 | |
13G/A | EcoR1 Capital, LLC | 0.00 | -100.00 | |
13G/A | BlackRock, Inc. | 3.00 | -3.24 | |
13D/A | Carlyle Group Inc. | 4.10 | 42.14 | |
13G/A | State Street Corp | 1.48 | -71.96 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
145,733 | 392,071 | 37.17 | |
159,329 | 410,940 | 38.77 | |
178,230 | 574,890 | 31.00 | |
(click for more detail) |
Similar Companies | |
---|---|
ACIU – AC Immune SA | ACRV – Acrivon Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io